group ACYW135 meningococcal conjugate vaccine

Group ACYW135 meningococcal conjugate vaccine is a quadrivalent vaccine developed by **Suzhou Weichao Biotechnology** for the prevention of invasive meningococcal disease caused by *Neisseria meningitidis* serogroups A, C, Y, and W135. The vaccine consists of capsular polysaccharides from each of the four serogroups chemically conjugated to a carrier protein to enhance immunogenicity, particularly in infants and young children, by inducing a T-cell dependent immune response. It is formulated as a lyophilized powder for injection and is currently undergoing clinical evaluation (e.g., CTR20213130) for safety and immunogenicity in healthy populations ranging from 2 months to 55 years of age.

Other names

冻干ACYW135群脑膜炎球菌结合疫苗Meningococcal polysaccharide groups A, C, Y and W135 conjugate vaccine